Chemed Corporation: Expansion into New Markets & New Locations For A Competitive Edge!

Chemed Corporation’s first-quarter results for 2025 provide a multifaceted view of the company’s performance across its businesses. Within its VITAS Healthcare unit, Chemed reported a solid overall performance, marked by a 15.1% increase in net revenue to $407.4 million compared to the same period the previous year. This growth was fueled primarily by an 11.9% rise in days of care and a geographically weighted average increase in Medicare reimbursement rates. The acquisition of Covenant Health, completed in April 2024, further enhanced the financials, adding a 3% to 4% boost to revenue, adjusted net income, and EBITDA.